Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    TODr. Tess O'Meara

    Dr. Tess O'Meara

    Hematology & Oncology · Breast Oncology
    Dana-Farber Cancer Institute
    drtessomeara
    Boston, MA

    Research

    Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing

    2025

    Via Current Oncology Reports

    Research

    Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the EMERALD Study

    2025

    Via Journal of Clinical Oncology

    Research

    Implementing a context-augmented large language model to guide precision cancer medicine

    2025

    Via medRxiv

    Research

    Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

    2025

    Via Journal of the National Cancer Institute

    Research

    Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors

    2025

    Via JCO Precision Oncology

    Research

    Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma, and healthy women

    2024

    Via mSystems

    Research

    Evidence of accelerated epigenetic aging of breast tissues in patients with breast cancer is driven by CpGs associated with polycomb-related genes

    2022

    Via Clinical Epigenetics

    Research

    Comprehensive Analysis of Metabolic Isozyme Targets in Cancer

    2022

    Via Cancer Research

    Research

    Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit

    2022

    Via JCO Precision Oncology

    Research

    Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer

    2022

    Via NPJ Breast Cancer

    Research

    Tumor mutational burden as a predictor of immunotherapy response in breast cancer

    2021

    Via Oncotarget

    Research

    Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

    2021

    Via Nature Communications

    Research

    Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

    2021

    Via Breast Cancer Research

    Research

    Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden

    2020

    Via Nature Communications

    Research

    Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers

    2020

    Via JCO Precision Oncology